Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Scientists in China have developed a modified virus that causes cancer cells to make sugars normally found in pigs, causing ...

Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...

Claire took on the route with her aim to raise funds for breast cancer patients in the Ulster Hospital who are undergoing ...

AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), ...

Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...

Sharni Marks, 31, was found to have a mutation in the BRCA2 gene back in 2018, which increases the risk of developing ovarian ...

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...

Updated results from the KATHERINE trial showed that adjuvant T-DM1 provided a significant improvement in overall survival and no evidence of long-term safety issues.

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...